NDC 0378-0197-05
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0378-0197
- Requested NDC
- 0378-0197-05
- Package NDCs from labels
- 0378-0197-05
- Manufacturer
- National Council for Prescription Drug Programs
- Effective date
- 2013-02-13
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| National Council for Prescription Drug Programs indexing - billing unit | National Council for Prescription Drug Programs | 2013-02-13 | Indexing - Billing Unit |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0378-0197-01 | EA - Each | 0378-0197 | 705c1658-2999-4e88-b00b-270645844035 | 1 | 2012-07-24 |
| 0378-0197-05 | EA - Each | 0378-0197 | 4ae28794-a74e-4ae7-bbf0-2fa45be72791 | 1 | 2013-02-13 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Allopurinol | ALLOPURINOL | Mylan Pharmaceuticals Inc. | bdbf5ad4-86f2-4e9c-a51a-fb0c7220c480 | 2025-11-20 | Warnings, Adverse reactions | Mylan Pharmaceuticals Inc. |
| BREYNA | BUDESONIDE AND FORMOTEROL FUMARATE | Mylan Pharmaceuticals Inc. | dc529fc4-bddb-4673-8202-dc401f86166f | 2025-11-15 | Warnings, Adverse reactions | Mylan Pharmaceuticals Inc. |
| Doxepin Hydrochloride | DOXEPIN HYDROCHLORIDE | Mylan Pharmaceuticals Inc. | 1533343b-f1ed-4c3a-bb36-23a748452b05 | 2025-10-15 | Boxed warning, Warnings, Adverse reactions | Mylan Pharmaceuticals Inc. |
| Methylphenidate | METHYLPHENIDATE | Mylan Pharmaceuticals Inc. | 1643b6a5-80da-4d4f-8c5f-feb907875702 | 2025-10-07 | Boxed warning, Warnings, Adverse reactions | Mylan Pharmaceuticals Inc. |
| Fenofibrate | FENOFIBRATE | Mylan Pharmaceuticals Inc. | 5b67f389-55e8-466b-82bd-5ea992f630aa | 2025-09-15 | Warnings, Adverse reactions | Mylan Pharmaceuticals Inc. |
| Perphenazine and Amitriptyline Hydrochloride | PERPHENAZINE AND AMITRIPTYLINE HYDROCHLORIDE | Mylan Pharmaceuticals Inc. | e2937445-c015-c9a5-52f8-a2959da97290 | 2025-08-30 | Boxed warning, Warnings, Adverse reactions | Mylan Pharmaceuticals Inc. |
| Clozapine | CLOZAPINE | Mylan Pharmaceuticals Inc. | 9ae4b8e4-d8b1-4f01-bb4c-cd1cea90b219 | 2025-08-15 | Boxed warning, Warnings, Adverse reactions | Mylan Pharmaceuticals Inc. |
| Fenofibrate | FENOFIBRATE | Mylan Pharmaceuticals Inc. | 0f958942-1504-40a1-8ad8-43df2c3f717e | 2025-08-15 | Warnings, Adverse reactions | Mylan Pharmaceuticals Inc. |
| Tacrolimus | TACROLIMUS | Mylan Pharmaceuticals Inc. | 45af3eda-caaa-4478-9372-95aa65adc9b3 | 2025-08-15 | Boxed warning, Warnings, Adverse reactions | Mylan Pharmaceuticals Inc. |
| Macitentan | MACITENTAN | Mylan Pharmaceuticals Inc. | d88a13e7-cf08-4632-86be-dcd979516296 | 2025-08-05 | Boxed warning, Warnings, Adverse reactions | Mylan Pharmaceuticals Inc. |
| Dabigatran Etexilate | DABIGATRAN ETEXILATE | Mylan Pharmaceuticals Inc. | baafb5be-ffe6-4755-a7ab-817b3c9b222d | 2025-07-30 | Boxed warning, Warnings, Adverse reactions | Mylan Pharmaceuticals Inc. |
| Carisoprodol | CARISOPRODOL | Mylan Pharmaceuticals Inc. | 7c9184c0-7a2e-11df-8c8d-0002a5d5c51b | 2025-07-15 | Warnings, Adverse reactions | Mylan Pharmaceuticals Inc. |
| Scopolamine | SCOPOLAMINE | Mylan Pharmaceuticals Inc. | 163accb7-45e6-4d97-844d-72b606677008 | 2025-07-08 | Warnings, Adverse reactions | Mylan Pharmaceuticals Inc. |
| Estradiol | ESTRADIOL | Mylan Pharmaceuticals Inc. | e7e6da3b-8485-1382-61c9-e9b369018b98 | 2025-06-23 | Boxed warning, Warnings, Adverse reactions | Mylan Pharmaceuticals Inc. |
| Eplerenone | EPLERENONE | Mylan Pharmaceuticals Inc. | 4286699b-2320-4d3d-831c-32085f36fb67 | 2025-06-23 | Warnings, Adverse reactions | Mylan Pharmaceuticals Inc. |
| Estradiol | ESTRADIOL | Mylan Pharmaceuticals Inc. | f4efb0bf-b96f-4e20-a0f2-0806ab92b2d4 | 2025-06-23 | Boxed warning, Warnings, Adverse reactions | Mylan Pharmaceuticals Inc. |
| Estradiol | ESTRADIOL | Mylan Pharmaceuticals Inc. | d28bec8f-762e-4f05-a20d-96a42970d6a7 | 2025-06-17 | Boxed warning, Warnings, Adverse reactions | Mylan Pharmaceuticals Inc. |
| Colestipol Hydrochloride | COLESTIPOL HYDROCHLORIDE | Mylan Pharmaceuticals Inc. | dae7d51e-c117-4c8a-b018-45b01ae46100 | 2025-05-13 | Adverse reactions | Mylan Pharmaceuticals Inc. |
| Colestipol Hydrochloride | COLESTIPOL HYDROCHLORIDE | Mylan Pharmaceuticals Inc. | 4e89bf6e-c78a-402e-9cb2-8d02f6047d68 | 2025-05-07 | Warnings, Adverse reactions | Mylan Pharmaceuticals Inc. |
| Ticagrelor | TICAGRELOR | Mylan Pharmaceuticals Inc. | fc333c4a-ad63-4d67-a3f7-431ac469d116 | 2025-04-14 | Boxed warning, Warnings, Adverse reactions | Mylan Pharmaceuticals Inc. |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.